Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

CDT Equity Inc. (CDT)

$3.06 -6.42% NASDAQ: CDT · 15-min delayed
  • NAPLES, Florida
  • Public · NASDAQ: CDT
  • 4 employees
$3.6MMarket cap
-$39.2MNet income
4Employees
CDTNASDAQ
2023IPO

About CDT Equity Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$39.2M
Total assets
$5.7M
Market cap
$3.6M

Source: SEC EDGAR · updated Jun 8, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$0
Operating expenses
$36.8M
Operating income
-$36.8M
Net income
-$39.2M
EPS (basic)
$-1,177.89
EPS (diluted)
$-1,177.89

Balance sheet

Total assets
$5.7M
Current assets
$4.4M
Total liabilities
$12.8M
Current liabilities
$12.8M
Shareholders’ equity
-$7.2M

Cash flow

Operating cash flow
-$15.6M
Investing cash flow
-$808.0K
Financing cash flow
$17.4M
Net cash flow
$1.1M

Statements via Polygon.io (SEC filings)

NASDAQ: CDT
$3.06 -6.42%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.06 $5,840.00

52-week range

Market cap
$3.6M
EPS (diluted)
$-1177.89
Shares outstanding
1.2M
Open
Day range
Prev close
Volume
IPO date
Sep 25, 2023

CDT Equity Inc. (CDT) Stock Price

  • Reported a net loss of $39.2M.
  • Trading 100% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review CDT Equity Inc..

Write a review
Newsroom

News about CDT Equity Inc.

News & sentiment via Polygon.io

FAQ

CDT Equity Inc.: frequently asked questions

Is CDT Equity Inc. an American company?

CDT Equity Inc. is a US-based company headquartered in Naples, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is CDT Equity Inc. headquartered?

CDT Equity Inc. is headquartered in Naples, Florida, United States.

Is CDT Equity Inc. publicly traded?

Yes — CDT Equity Inc. is a publicly traded company. Its stock trades under the ticker symbol CDT on the NASDAQ.

What does CDT Equity Inc. do?

CDT Equity Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →